Clinical Pharmacy Services in Ambulatory Oncology: An Environmental Scan of the Canadian Practice Landscape

被引:3
|
作者
Tibensky, Bryanna [1 ,2 ]
Hutton, Lauren [3 ,4 ]
Wentzell, Jason [2 ,5 ]
LeBlanc, Michael [6 ]
Edwards, Scott [7 ,8 ]
McFarlane, Thomas [2 ]
机构
[1] Univ Waterloo, Ctr Family Med Family Hlth Team, Waterloo, ON, Canada
[2] Univ Waterloo, Sch Pharm, Waterloo, ON, Canada
[3] Nova Scotia Hlth, Halifax, NS, Canada
[4] Beatrice Hunter Canc Res Inst, Halifax, NS, Canada
[5] Extend Pharm & Extend Hlth Solut, Ottawa, ON, Canada
[6] Horizon Hlth Network, New Brunswick, NJ USA
[7] Eastern Hlth, St John, NL, Canada
[8] Mem Univ St Johns, St John, NL, Canada
来源
CANADIAN JOURNAL OF HOSPITAL PHARMACY | 2022年 / 75卷 / 04期
关键词
clinical pharmacy key performance indicator; key performance indicator; ambulatory oncology; oncology pharmacy; outpatient oncology; Canada;
D O I
10.4212/cjhp.3208
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Canadian clinical pharmacy key performance indicators (cpKPIs) have been developed for inpatient hospital practice but are not established for ambulatory oncology. This study represents the first step in developing cpKPIs for ambulatory oncology.Objectives: To describe the current landscape of pharmacy services in ambulatory oncology in Canada and to identify perspectives related to the development and implementation of cpKPIs in this practice setting.Methods: In this national cross-sectional study, a web-based questionnaire was distributed to pharmacists working in ambulatory oncology settings. Potential participants who self-identified as pharmacists practising in an ambulatory oncology setting were eligible. Survey questions focused on participants' demographic characteristics, oncology pharmacy services provided, metrics captured, and pharmacists' perceptions of cpKPIs. All data were analyzed using descriptive statistics.Results: A total of 44 responses were received, with most respondents practising in community hospitals in British Columbia, Ontario, and Atlantic Canada. The services most commonly provided were chemotherapy order verification, laboratory monitoring, identification and resolution of drug therapy problems, and counselling on anticancer medications. Twenty-six of the 44 respondents (59%) indicated that performance metrics or patient outcomes were tracked at their respective institutions, with none being universally captured. Overall, 43 (98%) of the respondents favoured the development of cpKPIs for ambulatory oncology practice.Conclusions: Despite growing patient care needs in ambulatory oncology, there is significant heterogeneity in the scope of pharmacy services offered and the outcomes used to qualify their impact within this setting across Canada. This study demonstrates a clear need for national consensus cpKPIs to inform pharmacy resource utilization and patient -centred quality improvement initiatives.
引用
收藏
页码:259 / 266
页数:8
相关论文
共 50 条
  • [41] Feasibility and usefulness of the 'Distress Screening Program in Ambulatory Care' in clinical oncology practice
    Shimizu, Ken
    Ishibashi, Yuki
    Umezawa, Shino
    Izumi, Hideko
    Akizuki, Nobuya
    Ogawa, Asao
    Fujiwara, Yasuhiro
    Ando, Masashi
    Katsumata, Noriyuki
    Tamura, Kenji
    Kouno, Tsutomu
    Shimizu, Chikako
    Yonemori, Kan
    Yunokawa, Mayu
    Uchitomi, Yosuke
    [J]. PSYCHO-ONCOLOGY, 2010, 19 (07) : 718 - 725
  • [42] A survey about the contents and features of oncology clinical pharmacy services and self-evaluations of the oncology pharmacists in China
    Wang, Yanting
    Dai, Yuanyuan
    Yang, Jun
    Zhou, Haiyan
    Chen, Zhe
    Li, Guohui
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 (05) : 1106 - 1113
  • [43] Creation and Implementation of an Environmental Scan to Assess Cancer Genetics Services at Three Oncology Care Settings
    Bednar, Erica M.
    Walsh, Michael T., Jr.
    Baker, Ellen
    Muse, Kimberly I.
    Oakley, Holly D.
    Krukenberg, Rebekah C.
    Dresbold, Cara S.
    Jenkinson, Sandra B.
    Eppolito, Amanda L.
    Teed, Kelly B.
    Klein, Molly H.
    Morman, Nichole A.
    Bowdish, Elizabeth C.
    Russ, Pauline
    Wise, Emaline E.
    Cooper, Julia N.
    Method, Michael W.
    Henson, John W.
    Grainger, Andrew V.
    Arun, Banu K.
    Lu, Karen H.
    [J]. JOURNAL OF GENETIC COUNSELING, 2018, 27 (06) : 1482 - 1496
  • [44] ATTITUDINAL ASSESSMENT OF FAMILY-PRACTICE RESIDENTS TOWARD CLINICAL PHARMACY SERVICES
    THIES, PW
    HELLING, DK
    RAKEL, RE
    [J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1982, 16 (06): : 482 - 482
  • [45] 3RD-PARTY REIMBURSEMENT FOR CLINICAL PHARMACY SERVICES - PHILOSOPHY AND PRACTICE
    NOLD, EG
    PATHAK, DS
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1977, 34 (08): : 823 - 826
  • [46] Standards of practice for clinical pharmacy services - Chapter 16: My Health Record
    Bunte, Michelle
    [J]. JOURNAL OF PHARMACY PRACTICE AND RESEARCH, 2021, 51 (06) : 536 - 551
  • [47] Music Therapy Services in Pediatric Oncology: A National Clinical Practice Review
    Tucquet, Belinda
    Leung, Maggie
    [J]. JOURNAL OF PEDIATRIC ONCOLOGY NURSING, 2014, 31 (06) : 327 - 338
  • [48] The Impact of Clinical Pharmacy Services in a Tertiary Care Center Specialized in Pediatric Hemato-Oncology
    Gradwohl, Christina
    Engstler, Gernot
    Anditsch, Martina
    Pichler, Herbert
    Stemer, Gunar
    [J]. CHILDREN-BASEL, 2022, 9 (04):
  • [49] Using quality improvement frameworks to develop, implement, and evaluate a novel ambulatory oncology pharmacy practice model: A descriptive example
    Underhill, Hayley
    Leblanc, Michael
    Macfarlane, Robyn
    Hutton, Lauren
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2024,
  • [50] National survey on the effect of oncology drug shortages in clinical practice: A Hematology Oncology Pharmacy Association (HOPA) survey.
    Hudson-Disalle, Sarah
    DeRemer, David L.
    Buie, Larry W.
    Hamm, Mark
    Pilz, Jeffrey
    McBride, Ali
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)